IHAM
IMCR icon

Integral Health Asset Management’s Immunocore IMCR Stock Holding History

Integral Health Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100,000
Closed -$3.02M – 103
2026
Q1 		$3.02M Buy
+100,000
New +$3.24M 0.14% 83

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Integral Health Asset Management's IMCR Position: Q2 2026 in Review

Integral Health Asset Management sold out of Immunocore (IMCR) in Q2 2026, closing a stake of 100,000 shares — an estimated $3.02M sold.

Integral Health Asset Management first reported a position in IMCR in Q1 2026 and held it in 1 quarter. The position peaked at $3.02M in Q1 2026. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Integral Health Asset Management reported no remaining Immunocore position as of Q2 2026 after selling out during the quarter.
  • Integral Health Asset Management sold 100,000 Immunocore shares in Q2 2026, an estimated $3.02M.
  • Integral Health Asset Management first reported a position in Immunocore in Q1 2026 and held it in 1 quarter.
  • Integral Health Asset Management's Immunocore position peaked at $3.02M in Q1 2026.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.